Clinical trial
Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy…
NCT00161265 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00161265 |
|---|---|
| Title | Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer |
| Official title | UMCC 2004.064: Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | tissue procurement |
| Enrollment | 68 |
| Start date | May 1, 2005 |
| Primary completion | Aug 1, 2012 |
| Completion | Jun 1, 2016 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: